Immunological effects of BRAF plus MEK inhibition

Ascierto, PA; Dummer, R

Ascierto, PA (reprint author), IRCCS Fdn G Pascale, Ist Nazl Tumori, Unit Melanoma Canc Immunotherapy & Dev Therapeut, Naples, Italy.

ONCOIMMUNOLOGY, 2018; 7 (9):

Abstract

Recent developments in immunotherapy have prolonged overall survival in metastatic melanoma with the possibility to reach a long-term benefit. Targete......

Full Text Link